Related Experiment Video
Updated: Aug 8, 2026

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Degenerative Cervical Myelopathy: Towards a Personalized Approach
Nader Hejrati1, Ali Moghaddamjou2, Nandan Marathe2
1Division of Genetics and Development, Krembil Brain Institute, University Health Network, Toronto, ON, Canada.
Degenerative cervical myelopathy (DCM) involves spinal cord compression from various conditions. Personalized treatment approaches, including biomarkers and surgical strategies, are key for managing this complex spinal cord disorder.
Area of Science:
- Neurology
- Neurosurgery
- Spinal Cord Medicine
Background:
- Degenerative cervical myelopathy (DCM) is a clinical syndrome resulting from chronic spinal cord compression.
- Pathologies include cervical spondylotic myelopathy, degenerative disc disease, and ligamentous ossification.
- DCM presents with variable symptoms like impaired dexterity, gait disturbance, and sensorimotor deficits.
Purpose of the Study:
- To review current understanding and personalized treatment approaches for DCM.
- To address knowledge gaps and controversies in DCM diagnosis and management.
- To summarize diagnostic modalities and treatment strategies for chronic spinal cord compression.
Main Methods:
- Review of basic science studies on DCM pathophysiology.
- Analysis of clinical decision-making factors.
- Evaluation of surgical and non-operative treatment strategies.
- Discussion of diagnostic modalities.
Main Results:
- Understanding of DCM pathophysiology has advanced significantly.
- Personalized treatment strategies are emerging.
- Debates persist regarding optimal clinical decision-making, intervention timing, and surgical approaches.
- Heterogeneity in DCM etiology necessitates tailored patient management.
Conclusions:
- Personalized medicine, utilizing biomarkers and tailored surgical approaches, is crucial for optimizing DCM patient outcomes.
- Further research is needed to refine management strategies for this heterogeneous patient population.
- Addressing current controversies in DCM treatment is essential for improving patient care.
More Related Videos
11:57Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
05:17Author Spotlight: Scope of LE-ULBD as a Safe, Effective, and Minimally Invasive Approach to Treat Lumbar Spinal Stenosis
Published on: February 9, 2024
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology